Organization · Venture Capital
Innogest Capital
Innogest Capital is a venture capital firm based in Turin, Italy, with additional offices in Milan, Geneva, and San Francisco. It specializes in seed and early-stage investments in healthcare and technology sectors, focusing on innovative companies with global ambitions.
Overview
What Innogest Capital does
What Innogest Capital is
Innogest Capital is a venture capital firm based in Turin, Italy, with additional offices in Milan, Geneva, and San Francisco. It specializes in seed and early-stage investments in healthcare and technology sectors, focusing on innovative companies with global ambitions.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2006
- Approximate age
- About 20 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- April 23, 2026
Official channels
Find Innogest Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Innogest Capital as a funder
Investment thesis
Innogest Capital focuses on early-stage investments in healthcare and digital sectors, leveraging a strong Italian founder network and transatlantic connections for scaling companies.
Focus narrative
Innogest Capital invests in technology and healthcare sectors, targeting early-stage and growth-stage companies. The firm has a dual-vertical focus on healthcare, including medical devices and digital health, as well as digital sectors like foodtech and fintech.
Value beyond capital
Innogest Capital adds value to its portfolio companies through a robust network of Italian and international connections, providing strategic support for scaling operations and accessing new markets. The firm's expertise in healthcare and technology sectors enables it to guide startups effectively.
Terms and economics
- Typical check
- $250,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 43
- Recorded notable exits
- Silicon Biosystems, CornerJob, and Everli
Portfolio context
Notable portfolio companies include Anaconda Biomed, which develops a neuro-thrombectomy device; Newronika, a spin-off from the University of Milan; Everli, an Italian grocery delivery marketplace; and Silicon Biosystems, acquired by Menarini Group. Innogest has made approximately 87 investments, with 43 active portfolio startups and 12 exits.
Capability profile
Innogest Capital as an event host
Event focus
Innogest Capital primarily invests in the healthcare and technology sectors, with a strong emphasis on early-stage ventures. Their investment strategy targets companies with global ambitions, particularly in digital health, medical technologies, and digital platforms. The firm is particularly interested in addressing cardiovascular diseases, neurological disorders, and oncology.
Format narrative
Innogest Capital participates in various industry events and conferences, including the Italian Patents Competition award ceremony, which showcases innovative projects in the life sciences and digital sectors.
Participant value
Innogest Capital aims to promote the excellence of Italian research and enhance it on an international scale through initiatives like the Italian Patents Competition, which offers significant investment for innovative projects.
Format and cadence
- Event types
- awards-ceremony
- Startups can present
- Yes
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Pre-seed · Seed · Series A
- Audience
- Founders · Investors
- Regions
- EuropeNorth America
Capability profile
Innogest Capital as a publisher
Editorial focus
Innogest Capital is dedicated to investing in early-stage and growth-stage companies primarily within the technology and healthcare sectors. The firm leverages its deep Italian founder network and additional offices in Switzerland and California to support trans-Atlantic scale-up opportunities.
Audience value
Innogest Capital offers a strong fit for Italian and Southern European founders in medtech and digital sectors, providing thesis-aligned co-investment opportunities and a robust network for scaling their businesses.
Format and cadence
- Content formats
- blog
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Investors
- Regions
- Europe
Flagship work and coverage
Flagship properties
Innogest Capital I and Innogest Capital II are the main funds, with a focus on seed and early-stage investments in Italy and beyond.
Notable coverage
Innogest Capital has been featured in various publications for its investments in notable companies such as Anaconda Biomed, Newronika, and Silicon Biosystems, highlighting its successful exits and active portfolio.
Common questions
What to know about Innogest Capital
Upseed classifies Innogest Capital under the Venture Capital organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.